DelveInsight launched a report on Hot Flashes Market Insights, Epidemiology, and Market Forecast 2030.
Vasomotor symptoms (VMS) or Hot Flashes are the most commonly reported menopausal symptoms, characterized by a sudden increase of blood flow, often to the face, neck, and chest, that causes the sensation of extreme heat and profuse sweating. When symptoms occur at night they are called “night sweats” and can cause significant sleep disturbances. Episodes of vasomotor symptoms can last 1 to 5 minutes and can be associated with perspiration, flushing, chills, anxiety, and even heart palpitations.
DelveInsight’s “Hot Flashes Market Report 2030“ delivers an in-depth understanding of the Hot Flashes, historical and forecasted epidemiology as well as the Hot Flashes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Study Period: 2017-2030
Hot Flashes Disease Understanding and Treatment Algorithm
Hot Flashes are a form of temperature dysfunction that occurs due to changes in gonadal hormones. Normally, core body temperature (CBT) remains within a specific range, oscillating with daily circadian rhythms. Physiological processes that conserve and dissipate heat are responsible for maintaining CBT, and tight regulation is important for the maintenance of optimal internal organ function. Disruption of this tightly controlled temperature circuit results in exaggerated heat-loss responses and presents as VMS. The mechanistic role related to changes in gonadal hormones associated with Hot Flashes is not understood.
VMEs can have marked effects on personal and professional performance, especially when they are associated with other estrogen-deficiency brain dysfunction, such as sleep cycle disintegration, cognitive disorders, and neuroendocrine dysfunction. In women who need relief for mild vasomotor symptoms, NAMS recommends first considering lifestyle changes, either alone or combined with a nonprescription remedy, such as dietary isoflavones, black cohosh, or vitamin E.
The DelveInsight Hot Flashes market report gives a thorough understanding of the Hot Flashes by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment.
Hot Flashes Epidemiology
The Hot Flashes epidemiology division provide insights about historical and current Hot Flashes patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
“Among the European countries, Germany had the highest prevalent population of Vasomotor Symptoms, followed by France. On the other hand, Spain had the lowest prevalent population of Vasomotor Symptoms.”
Request a free sample copy of the report @https://www.delveinsight.com/sample-request/hot-flashes-market
Key pharma players involved:
- Astellas Pharma
- Fervent Pharmaceuticals
- Mithra Pharmaceuticals
Hot Flashes Market Outlook
Hot Flashes refer to the sudden sensation of extreme heat in the upper body, particularly the face, neck, and chest. The current therapeutic landscape of hot flashes associated with menopause in the US can be divided into two major categories based on the class of drug. These are Hormonal Therapies and Nonhormonal Therapy. Systemic hormone replacement therapy, with estrogen alone or in combination with a progestin, is the most effective therapy for vasomotor symptoms related to menopause.
According to DelveInsight, Hot Flashes market in 7MM is expected to change in the study period 2017-2030.
1. The market size of hot flashes associated with post-menopause in the seven major market was found to be 1,755.8 Million in 2018.
2. Among the 7MM, the US accounts for the 61% USD of the overall market size of hot flashes associated with post-menopause in 2018.
Table of contents:
1. Key Insights
2. Executive Summary of Hot Flashes
3. Competitive Intelligence Analysis for Hot Flashes
4. Hot Flashes: Market Overview at a Glance
5. Hot Flashes: Disease Background and Overview
6. Patient Journey
7. Hot Flashes Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Hot Flashes Treatment
11. Marketed Products
12. Emerging Therapies
13. Hot Flashes: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Hot Flashes
17. KOL Views
18. Market Drivers
19. Market Barriers
21. DelveInsight Capabilities
23. About DelveInsight
*The table of contents is not exhaustive; the final content may vary.
- Hot Flashes – Market Insights, Epidemiology and Market Forecast-2027
- Hot Flashes – Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
- Hot Flashes – Pipeline Insights, 2020
- Hot Flashes – Epidemiology Forecast to 2030
- Vasomotor symptoms (Hot flashes/Night sweats)– Epidemiology Forecast—2030
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States